Homrich & Berg’s MiMedx Group MDXG Stock Holding History

Homrich & Berg’s Portfolio MDXG Stock Details MDXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-23,367	Closed	-$163K	–	340
2018 Q1	$163K	Hold	23,367	–	–	0.01%	318
2017 Q4	$295K	Hold	23,367	–	–	0.02%	257
2017 Q3	$278K	Hold	23,367	–	–	0.02%	260
2017 Q2	$350K	Hold	23,367	–	–	0.03%	199
2017 Q1	$223K	Hold	23,367	–	–	0.02%	272
2016 Q4	$207K	Buy	23,367 +5,993	+34%	+$53.8K	0.02%	262
2016 Q3	$149K	Buy	17,374 +7	+0%	+$55	0.01%	268
2016 Q2	$139K	Hold	17,367	–	–	0.01%	258
2016 Q1	$152K	Sell	17,367 -5,000	-22%	-$41.5K	0.02%	254
2015 Q4	$210K	Sell	22,367 -500	-2%	-$4.33K	0.02%	241
2015 Q3	$221K	Buy	22,867 +500	+2%	+$5.28K	0.02%	239
2015 Q2	$259K	Hold	22,367	–	–	0.03%	220
2015 Q1	$233K	Hold	22,367	–	–	0.02%	221
2014 Q4	$258K	Hold	22,367	–	–	0.03%	197
2014 Q3	$159K	Buy	22,367 +5,000	+29%	+$34.9K	0.02%	228
2014 Q2	$123K	Hold	17,367	–	–	0.01%	200
2014 Q1	$106K	Sell	17,367 -16,950	-49%	-$125K	0.01%	200
2013 Q4	$300K	Buy	+34,317	New	+$210K	0.04%	158
2013 Q3	–	Sell	-34,317	Closed	-$242K	–	144
2013 Q2	$242K	Buy	+34,317	New	+$240K	0.04%	131

Other funds holding MDXG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Tiedemann Advisors New York $2.33B AUM 15.56% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Homrich & Berg's MDXG Position: Q2 2018 in Review

Homrich & Berg sold out of MiMedx Group (MDXG) in Q2 2018, closing a stake of 23,367 shares — an estimated $163K sold.

Homrich & Berg first reported a position in MDXG in Q2 2013 and held it in 19 quarters. The position peaked at $350K in Q2 2017. 213 funds tracked by Wall St. Rank hold MDXG as of Q2 2018.

Homrich & Berg reported no remaining MiMedx Group position as of Q2 2018 after selling out during the quarter.
Homrich & Berg sold 23,367 MiMedx Group shares in Q2 2018, an estimated $163K.
Homrich & Berg first reported a position in MiMedx Group in Q2 2013 and held it in 19 quarters.
Homrich & Berg's MiMedx Group position peaked at $350K in Q2 2017.
213 funds tracked by Wall St. Rank held MiMedx Group as of Q2 2018.

Based on Homrich & Berg's 13F filing for Q2 2018, filed 9 Aug 2018.